This text is a result of machine translation.
Cro plate fell, and Wuxi apptec fell nearly 10%
Singaporean Prime Minister Lee Hsien Loong meets with weifenghe
BiliBili CEO Chen Rui: station B will officially resume work on June 13
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
The revenue of BiliBili in the first quarter was RMB 5.054 billion, which is expected to be RMB 5.042 billion.
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions
Apr 25, 2025 11:24 PM
SAIC MAXUS Partners with Huawei Qiankun, Multiple Models to be Launched
Apr 25, 2025 08:41 PM
Chinese Carmakers Expanding into Europe: Beware of Four Major Misconceptions
Apr 22, 2025 09:32 PM
Perfect Timing: Chagee Bridges the Cultural Gap in the U.S. Tea Market
Apr 22, 2025 03:29 PM